In February 2019, NHS Greater Glasgow and Clyde was announced as this year’s recipient of Microsoft Corporation’s 2019 Health Innovation Awards in the Artificial Intelligence (AI) and Machine Learning (ML) category.
The awards, which were announced at the 2019 HIMSS Annual Conference and Exhibition in Orlando, Florida, recognise health organisations and their technology solution partners for using Microsoft’s intelligent health technologies in innovative ways that help empower care teams, improve clinical and operational outcomes, and advance precision healthcare.
NHSGGC was recognised for its work with KenSci in the use of Artificial Intelligence and Machine Learning to help combat Chronic Obstructive Pulmonary Disorder (COPD) and related issues, which affects nearly 1.6 million people in the UK.
The partnership with KenSci, Storm ID, ResMed and funding from Innovate UK, seeks to reduce emergency hospital admissions among the highest risk COPD patients through remote monitoring, home therapy, and AI-enabled preventative interventions.
By remotely monitoring patients’ COPD symptoms, physiology and treatment in the home, machine learning algorithms offer healthcare professionals clinical decision support to target patients at high risk of an exacerbation.
Dr. David Lowe, Consultant Emergency Medicine and Dr. Chris Carlin, Consultant Respiratory Physician, NHSGGC were the lead clinicians in the project.